Aurobindo Pharma informs about press release

17 Jul 2023 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Aurobindo Pharma has informed that the U.S. Food and Drug Administration (FDA) conducted an inspection at Aurobindo Pharma, Unit XIV, FEI 3014477031, located at Plot No 17, E-Bonangi Village, Jawaharlal Nehru Pharma City, Parawada Mandal, Anakapalli District, Andhra Pradesh, from 15th May to 19th May 2023. The Unit has now received Establishment Inspection Report classifying the facility as ‘Voluntary action indicated’ (‘VAI’).

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1121.65 -18.65 (-1.64%)
21-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.55
Dr. Reddys Lab 1155.50
Cipla 1369.55
Zydus Lifesciences 876.10
Lupin 2139.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×